View our Product Catalog to find products you can try for free.
Learn the results of the ADVOCATE clinical trial, which showed the impact of a ceramide infused skin barrier on cost of care and patient satisfaction.
The ADVOCATE trial is a double-blinded, randomized, controlled study. It compares ostomy-related costs and incidence of peristomal skin complications (PSCs) for a ceramide infused ostomy skin barrier versus a control skin barrier.
This type of evidence offers credible data to help support evidence-based clinical decision making. It also demonstrates positive outcomes with the use of a ceramide infused barrier – the CeraPlus™ skin barrier with Remois Technology.* The CeraPlus™ skin barrier is carefully formulated, and infused with ceramide, to create an environment where healthy skin can thrive.
Read this article in the Journal of Wound, Ostomy, and Continence Nursing to learn about the ADVOCATE trial. You can also watch this video, in which the study authors discuss the experience of participating in the trial and give their clinical perspectives on the results.
*Remois is a technology of Alcare Co., Ltd.
Find out the lessons learned from the ADVOCATE clinical trial, including the relationship between peristomal skin complications and risk factors.Read More
Let us help you find the CeraPlus™ Products* that will give the people you care for the security they need to enable healthy skin in their daily life.Read More
Learn about how an international panel of experts is making it easier to evaluate and choose convex ostomy skin barriers.Read More
Prior to use, be sure to read the Instructions for Use for information regarding Intended Use, Contraindications, Warnings, Precautions, and Instructions.
The information provided herein is not medical advice and is not intended to substitute for the advice of your personal physician or other healthcare provider. This information should not be used to seek help in a medical emergency. If you experience a medical emergency, seek medical treatment in person immediately.
Sorry, but we were unable to load this content. Please try again.
You are now leaving the Hollister Incorporated website and are going to a website that is not operated by us. Hollister Incorporated is not responsible for the content on or availability of linked sites. Please be aware that linked sites may have different security or privacy policies.